fbpx
Knowledge is the first and last step to investing

Aurobindo Pharma says the U.S. health regulator has issued three observations after inspecting the Andhra Pradesh-based manufacturing unit of its subsidiary.

Recommended For You

Next Post
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?